Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Japan / NCT06377592
Recruiting Observational

Development and Accuracy Evaluation of Gram Staining Analysis AI

NCT06377592 · tracked via the Priya Life Science Japan tracker
Sponsor
GramEye
Phase
Observational
Started
2023-05-10
Last updated
2024-04-22

Condition(s) studied

Bacterial Infections

Investigational drug(s) / intervention(s)

Sample collection without intervention

Sample collection without intervention: No Intervention

Study summary

The investigators use Gram-stained specimens provided from clinical settings to develop and evaluate the accuracy of Gram staining analysis AI

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients in whom a Gram stain test was ordered Exclusion Criteria: * No exclusion criteria

Primary outcome measure(s)

  • Advanced level of blood culture Gram stain analysis AI accuracy — Day1
    Analyzing Gram-stained microscopic images of blood culture-positive specimens using AI and evaluating the accuracy of bacterial species estimation For example, classify GPC clusters as S. aureus or CNS.
  • Ordinary level of blood culture Gram stain analysis AI accuracy — Day1
    Gram-stained microscopic images of blood culture-positive specimens are analyzed using AI, and bacteria are classified based on morphological classification. For example, gram-positive cocci (GPC) are classified into gram-positive staphylococci (GCP clusters) and gram-positive streptococci (GPC chains).

Trial sites (1)

FacilityCityRegionStatus
Osaka University Hospital Suita Osaka Recruiting

More GramEye trials in Japan

Development and Evaluation of AI Program for Predicting Bacterial Species From Urine Gram Stain Specimens Recruiting
Development and Evaluation of Rapid Bacterial Species Identification for Acid-Fast Bacilli Smear Using Image Analysis AI Recruiting

Other trials for the same condition

Development and Evaluation of AI Program for Predicting Bacterial Species From Urine Gram Stain Specimens Recruiting
Development and Evaluation of Rapid Bacterial Species Identification for Acid-Fast Bacilli Smear Using Image Analysis AI Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06377592 on ClinicalTrials.gov ↗ ← All trials in Japan